Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;12(12):20-29.

Expanding medication options for pediatric ADHD

Tanya E Froehlich  1 , Sergio V Delgado  2 , Julia S Anixt  1
Affiliations

Expanding medication options for pediatric ADHD

Tanya E Froehlich et al. Curr Psychiatr. 2013 Dec.
No abstract available

PubMed Disclaimer

References

    1. Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res. 1998;94(1):127–152. - PubMed
    1. Wolraich M, Brown L, Brown RT, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–1022. - PMC - PubMed
    1. Pliszka S Issues AWGoQ. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46(7):894–921. - PubMed
    1. Zametkin AJ, Ernst M. Problems in the management of attention-deficit-hyperactivity disorder. The New England journal of medicine. 1999;340(1):40–46. - PubMed
    1. Goldman LS, Genel M, Bezman RJ, et al. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA : the journal of the American Medical Association. 1998;279(14):1100–1107. - PubMed

LinkOut - more resources